BeOne Medicines

NCT07820891

Phase 1Not yet recruiting202624 people15 Sept 2026clinicaltrials.gov

NCT07770698

Phase 1/2Not yet recruiting202630 people18 Aug 2026clinicaltrials.gov

NCT07715396

CollaboratorPhase 3Not yet recruiting2026230 people20 Jul 2026clinicaltrials.gov

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

CollaboratorPhase 2Recruiting202539 people14 Jan 2026clinicaltrials.gov

NCT07043400

Phase 3Recruiting2025351 people29 Jun 2025clinicaltrials.gov

NCT05152147

CollaboratorPhase 3Active, not recruiting2021920 people9 Dec 2021clinicaltrials.gov

NCT04973605

Phase 1/2Recruiting2021246 people22 Jul 2021clinicaltrials.gov